Page 32 - Vitamin D and Cancer

1 Vitamin D: Synthesis and Catabolism 19

16. Pols HA, Birkenhager JC, Foekens JA, van Leeuwen JP (1990) Vitamin D: a modulator of
cell proliferation and differentiation. J Steroid Biochem Mol Biol 37(6):873–876
17. Saez S, Falette N, Guillot C, Meggouh F, Lefebvre MF, Crepin M (1993) William L.
McGuire Memorial Symposium. 1,25(OH)2D3 modulation of mammary tumor cell growth
in vitro and in vivo. Breast Cancer Res Treat 27(1–2):69–81
18. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D (1994)
Antiproliferative effects of 1, 25-dihydroxyvitamin D3 on primary cultures of human pros-
tatic cells. Cancer Res 54(3):805–810
19. Adams JS, Clemens TL, Parrish JA, Holick MF (1982) Vitamin-D synthesis and metabolism
after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med
306(12):722–725
20. Garland CF, Garland FC (1980) Do sunlight and vitamin D reduce the likelihood of colon
cancer? Int J Epidemiol 9(3):227–231
21. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O (1985) Dietary
vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men.
Lancet 1(8424):307–309
22. Peterlik M, Cross HS (2005) Vitamin D and calcium deficits predispose for multiple chronic
diseases. Eur J Clin Invest 35(5):290–304
23. Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential
for anticancer therapeutics. Nat Rev Cancer 7(9):684–700
24. Cross HS, Peterlik M, Reddy GS, Schuster I (1997) Vitamin D metabolism in human colon
adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-
hydroxylase activity and regulation of side-chain metabolism. J Steroid Biochem Mol Biol
62(1):21–28
25. Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M (2001) 25-hydroxy-vitamin d metabo-
lism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun
285(4):1012–1017
26. Bises G, Kallay E, Weiland T et al (2004) 25-hydroxyvitamin D3-1alpha-hydroxylase
expression in normal and malignant human colon. J Histochem Cytochem 52(7):985–989
27. Kallay E, Bises G, Bajna E et al (2005) Colon-specific regulation of vitamin D hydroxylases – a
possible approach for tumor prevention. Carcinogenesis 26(9):1581–1589
28. Young MV, Schwartz GG, Wang L et al (2004) The prostate 25-hydroxyvitamin D-1 alpha-
hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate
cancer chemoprevention by vitamin D. Carcinogenesis 25(6):967–971
29. Anderson PH, O’Loughlin PD, May BK, Morris HA (2005) Modulation of CYP27B1 and
CYP24 mRNA expression in bone is independent of circulating 1, 25(OH)(2)D(3) levels.
Bone 36(4):654–662
30. Feskanich D, Ma J, Fuchs CS et al (2004) Plasma vitamin D metabolites and risk of colorec-
tal cancer in women. Cancer Epidemiol Biomarkers Prev 13(9):1502–1508
31. Bertone-Johnson ER, Chen WY, Holick MF et al (2005) Plasma 25-hydroxyvitamin D and
1, 25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev
14(8):1991–1997
32. Tuohimaa P, Tenkanen L, Ahonen M et al (2004) Both high and low levels of blood vitamin
D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study
in the Nordic countries. Int J Cancer 108(1):104–108
33. Rowling MJ, Kemmis CM, Taffany DA, Welsh J (2006) Megalin-mediated endocytosis of
vitamin d binding protein correlates with 25-hydroxycholecalciferol actions in human mam-
mary cells. J Nutr 136(11):2754–2759
34. Lechner D, Kallay E, Cross HS (2006) 1alpha, 25-Dihydroxyvitamin D(3) downregulates
CYP27B1 and induces CYP24A1 in colon cells. Mol Cell Endocrinol 263(1–2):55–64
35. Hsu JY, Feldman D, McNeal JE, Peehl DM (2001) Reduced 1alpha-hydroxylase activity in
human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin
D3-induced growth inhibition. Cancer Res 61(7):2852–2856